ABEO ABEONA THERAPEUTICS INC.
Price Chart
Executive Summary
A cluster of insider sales at ABEO Therapeutics: CEO, CFO, Chief Commercial Officer, and Chief Legal Officer collectively sold ~$540K in open-market transactions over two days (June 8-9, 2026) at ~$5.30-$5.43/share. While the dollar amount is modest relative to the $307M market cap (~0.18%), the participation of the entire C-suite in a coordinated sell-off is notable. The cluster is amplified by cross-filing context (cluster-insider-trades + cluster-offering-context), suggesting potential upcoming dilutive activity or other material developments.
Key Financial Metrics
Actionable Insight
The simultaneous C-suite sell-off at a biotech with 92% analyst bullishness is a red flag. Monitor for an S-3 shelf filing or other dilutive offering in the next 30 days — the cross-filing actuarial verdicts strongly amplify this cluster's signal. If no offering materializes within 2 weeks, the sales may be tax/planning related, but the coordination warrants caution.
Key Facts
- CEO Vishwas Seshadri sold 56,344 shares for ~$302K on June 8-9.
- CFO Joseph Vazzano sold 23,692 shares for ~$127K on June 8-9.
- Chief Commercial Officer Madhav Vasanthavada sold 9,620 shares for ~$52K on June 8-9.
- SVP/Chief Legal Officer Brendan O'Malley sold 11,131 shares for ~$60K on June 8-9.
- Total insider sales of ~$540K represent ~0.18% of ABEO's $307M market cap.
- All four C-suite officers sold on both June 8 and June 9 at similar prices, suggesting coordinated timing.
- Cross-filing context shows cluster-insider-trades + cluster-offering-context as an amplifier, raising the probability of a near-term dilutive offering.
Financial Impact
~$540K in insider sales, ~0.18% of market cap
Risk Factors
- Potential near-term dilutive equity offering signaled by cross-filing amplifier
- C-suite selling at a price near recent highs (~$5.43) may indicate insider view that stock is fairly valued or overvalued
- Historical calibration shows score-6 filings in this segment have only 34% observed up-move probability at T+20, with negative net alpha
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ABEO-1781051614054 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
2d ago
|
8-K
| $5.54 awaiting T+1 | awaiting T+1 | — | $5.53 (−0.18%) |
|
Jun 10, 2026
4d ago
|
8-K
| $5.35 awaiting T+1 | awaiting T+1 | — | $5.53 (+3.36%) |
|
Jun 10, 2026
5d ago
|
Insider Cluster
| $5.45 awaiting T+1 | awaiting T+1 | — | $5.53 (−1.56%) |
|
Jun 4, 2026
10d ago
|
8-K
| $5.82 $5.46 | ▼ −6.19% | ▼ −3.59% | $5.53 (−4.98%) |
|
May 22, 2026
23d ago
|
Insider Cluster
| $5.49 $5.69 | ▲ +3.64% | ▲ +3.63% | $5.53 (+0.73%) |
|
May 13, 2026
4w ago
|
8-K
| $5.71 $5.60 | ▼ −1.93% | ▼ −2.70% | $5.53 (−3.15%) |
|
May 13, 2026
4w ago
|
Press Release
| $5.71 $5.60 | ▼ −1.93% | ▼ −2.70% | $5.53 (−3.15%) |
|
May 4, 2026
5w ago
|
DEFA14A
| $5.83 $6.01 | ▲ +3.09% | ▲ +1.70% | $5.53 (−5.15%) |
|
Apr 7, 2026
9w ago
|
8-K
| $4.81 $4.87 | ▲ +1.25% | ▼ −1.29% | $5.53 (+14.97%) |
|
Apr 2, 2026
10w ago
|
Press Release
| $4.82 $4.76 | ▼ −1.24% | ▼ −1.72% | $5.53 (+14.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access